Skip to content

NRIX · Nurix Therapeutics, Inc.

Healthcare · −2.1% on Oct 16

☆ Add to watchlist

Updated Oct 17 · 9 feeds behind: FDA drug approvals, 2 days, and 8 more · Every feed →

On this page

The market view

Price chart

The interactive NRIX chart (by TradingView) loads here.

Our take

1 rule fired on NRIX

In short: none of these rules has solid or some evidence yet, so they show no clear lean on NRIX.

How each did in past tests, against similar stocks over 3 months. Past results don't predict future ones.

The 0–100 score for NRIX, and which of these rules are open on it right now
Members see one number for how strongly these rules agree on NRIX, and the day each rule fired. Better-tested rules count more, and so do different kinds of filings that point the same way.
See pricing →
Already a member? Sign in

Compare with this company’s history

Is disclosure activity unusual?

See how many different insiders or members of Congress reported purchases or sales of NRIX. Each bar covers 28 days, by disclosure date. Several trades by one person count once in each group and period.

Latest period: Sep 22, 2026–Oct 19, 2026 · UTC dates · today is excluded

Insider sales

Short history

Only 3 earlier periods are on file to compare with. We need at least 6 full periods before calling a count unusual.

Latest 28 days
3
Earlier median
2
Earlier range
1–3
Distinct filers per 28 daysScale: 0–3
Oct 21, 2025Oct 19, 2026
Earlier periodsLatest 28 daysEarlier median 2Limited or missing history

Who appears in the latest period?

Up to three filers; one example disclosure each.

Inspect this period’s filings

The history behind this view

First stored company disclosure: Jun 25, 2026. Newest disclosure across this feed: Oct 16, 2026.

Earlier periods in the comparison: 3. Outlined periods are missing data, so they are left out of the comparison. The chart scale changes with the category.

Exact counts, dates and filings for all four categories
Insider purchases · Short history

Only 3 earlier periods are on file to compare with. We need at least 6 full periods before calling a count unusual. Earlier median: 0; range: 0–0.

Insider purchases: distinct filers in stored disclosures
Period and filingsFilersHistory
Oct 21, 2025–Nov 17, 2025—Unavailable
Nov 18, 2025–Dec 15, 2025—Unavailable
Dec 16, 2025–Jan 12, 2026—Unavailable
Jan 13, 2026–Feb 9, 2026—Unavailable
Feb 10, 2026–Mar 9, 2026—Unavailable
Mar 10, 2026–Apr 6, 2026—Unavailable
Apr 7, 2026–May 4, 2026—Unavailable
May 5, 2026–Jun 1, 2026—Unavailable
Jun 2, 2026–Jun 29, 20260Partial; excluded
Jun 30, 2026–Jul 27, 20260Within stored history
Jul 28, 2026–Aug 24, 20260Within stored history
Aug 25, 2026–Sep 21, 20260Within stored history
Sep 22, 2026–Oct 19, 2026Latest period0Within stored history
Insider sales · Short history

Only 3 earlier periods are on file to compare with. We need at least 6 full periods before calling a count unusual. Earlier median: 2; range: 1–3.

Insider sales: distinct filers in stored disclosures
Period and filingsFilersHistory
Oct 21, 2025–Nov 17, 2025—Unavailable
Nov 18, 2025–Dec 15, 2025—Unavailable
Dec 16, 2025–Jan 12, 2026—Unavailable
Jan 13, 2026–Feb 9, 2026—Unavailable
Feb 10, 2026–Mar 9, 2026—Unavailable
Mar 10, 2026–Apr 6, 2026—Unavailable
Apr 7, 2026–May 4, 2026—Unavailable
May 5, 2026–Jun 1, 2026—Unavailable
Jun 2, 2026–Jun 29, 20262Partial; excluded
Jun 30, 2026–Jul 27, 20261Within stored history
Jul 28, 2026–Aug 24, 20263Within stored history
Aug 25, 2026–Sep 21, 20262Within stored history
Sep 22, 2026–Oct 19, 2026Latest period3Within stored history
Congress purchases · History unavailable

No completed-period disclosures for this company are available in this source. Missing history is not zero activity. Earlier median: —; range: unavailable.

Congress purchases: distinct filers in stored disclosures
Period and filingsFilersHistory
Oct 21, 2025–Nov 17, 2025—Unavailable
Nov 18, 2025–Dec 15, 2025—Unavailable
Dec 16, 2025–Jan 12, 2026—Unavailable
Jan 13, 2026–Feb 9, 2026—Unavailable
Feb 10, 2026–Mar 9, 2026—Unavailable
Mar 10, 2026–Apr 6, 2026—Unavailable
Apr 7, 2026–May 4, 2026—Unavailable
May 5, 2026–Jun 1, 2026—Unavailable
Jun 2, 2026–Jun 29, 2026—Unavailable
Jun 30, 2026–Jul 27, 2026—Unavailable
Jul 28, 2026–Aug 24, 2026—Unavailable
Aug 25, 2026–Sep 21, 2026—Unavailable
Sep 22, 2026–Oct 19, 2026Latest period—Unavailable
Congress sales · History unavailable

No completed-period disclosures for this company are available in this source. Missing history is not zero activity. Earlier median: —; range: unavailable.

Congress sales: distinct filers in stored disclosures
Period and filingsFilersHistory
Oct 21, 2025–Nov 17, 2025—Unavailable
Nov 18, 2025–Dec 15, 2025—Unavailable
Dec 16, 2025–Jan 12, 2026—Unavailable
Jan 13, 2026–Feb 9, 2026—Unavailable
Feb 10, 2026–Mar 9, 2026—Unavailable
Mar 10, 2026–Apr 6, 2026—Unavailable
Apr 7, 2026–May 4, 2026—Unavailable
May 5, 2026–Jun 1, 2026—Unavailable
Jun 2, 2026–Jun 29, 2026—Unavailable
Jun 30, 2026–Jul 27, 2026—Unavailable
Jul 28, 2026–Aug 24, 2026—Unavailable
Aug 25, 2026–Sep 21, 2026—Unavailable
Sep 22, 2026–Oct 19, 2026Latest period—Unavailable
How to read this comparison

The median is the middle count in up to 12 earlier, non-overlapping 28-day periods; the range runs from the smallest to the largest count. The latest period is excluded from both. A comparison needs at least 6 earlier periods, including 3 with activity. The feed’s latest disclosure must be within 7 days of the current period’s end. This freshness check does not verify complete collection.

Insiders include individuals and reporting entities; only purchase and sale codes enter this view. Congress counts reporting members, including their disclosed family transactions. The same filer can appear in purchases and sales, so these categories should not be added into a net count.

These are stored disclosures, not a complete measure of trading. Reporting delays and collection gaps can change the comparison. More activity does not identify a motive or predict a stock’s return.

Company timeline

What has been happening?

May 1, 2026–Oct 16, 2026. Select a month in a category to inspect its records.

Company filings

Insiders

Owners & lobbying

Company filings · Oct 2026

  1. Filed
  2. Record date
    Auditor doubts the company can continue ↗

    10-Q for the period ending Aug 31, 2026

  3. Filed
All 34 records in this snapshot
  1. Disclosed
    Gwenn Hansen · Sale

    Transaction dated Oct 15, 2026

  2. Disclosed
    Julia P Gregory · Sale

    Transaction dated Oct 14, 2026

  3. Filed
  4. Filed
  5. Record date
    Auditor doubts the company can continue ↗

    10-Q for the period ending Aug 31, 2026

  6. Filed
  7. Disclosed
    Christine Ring · Sale

    Transaction dated Oct 2, 2026

  8. Filed
  9. Filed
  10. Disclosed
    Christine Ring · Sale

    Transaction dated Sep 2, 2026

  11. Disclosed
    Christine Ring · Sale

    Transaction dated Sep 2, 2026

  12. Filed
  13. Disclosed
    Gwenn Hansen · Sale

    Transaction dated Sep 1, 2026

  14. Filed
  15. Filed
  16. Disclosed
    Gwenn Hansen · Sale

    Transaction dated Aug 4, 2026

  17. Disclosed
    Gwenn Hansen · Sale

    Transaction dated Aug 4, 2026

  18. Disclosed
    Gwenn Hansen · Sale

    Transaction dated Aug 5, 2026

  19. Filed
  20. Disclosed
    Houte Hans van · Sale

    Transaction dated Aug 4, 2026

  21. Disclosed
    Houte Hans van · Sale

    Transaction dated Aug 4, 2026

  22. Filed
  23. Disclosed
    Christine Ring · Sale

    Transaction dated Aug 3, 2026

  24. Filed
  25. Disclosed
    Christine Ring · Sale

    Transaction dated Jul 30, 2026

  26. Disclosed
    Gwenn Hansen · Sale

    Transaction dated Jul 30, 2026

  27. Disclosed
    Houte Hans van · Sale

    Transaction dated Jul 30, 2026

  28. Filed
  29. Filed
  30. Disclosed
    Christine Ring · Sale

    Transaction dated Jul 2, 2026

  31. Disclosed
    Christine Ring · Sale

    Transaction dated Jun 25, 2026

  32. Disclosed
    Gwenn Hansen · Sale

    Transaction dated Jun 25, 2026

  33. Filed
  34. Filed

Month counts include every record on file. The lists show the newest records on this page. A dash means none on file that month. Trades use disclosure dates; contract dates follow the source record. Nearby events do not establish the cause of a price move.

Who's buying and selling · last 90 days

Congress

No Congress trades on NRIX disclosed in the last 90 days.

See every Congress trade on NRIX →

Company insiders

0 buys · 11 sells (15 filed lots) · $1.8M sold

  1. ▼ SELLGwenn Hansen Chief Scientific OfficerNRIX Nurix Therapeutics, Inc.$36.3Kdisclosed Oct 15 · filed the same day
  2. ▼ SELLJulia P Gregory DirectorNRIX Nurix Therapeutics, Inc.$529Kdisclosed Oct 14 · filed the same day
  3. ▼ SELLChristine Ring Chief Legal OfficerNRIX Nurix Therapeutics, Inc.$134Kdisclosed Oct 2 · filed the same day
  4. ▼ SELLChristine Ring Chief Legal OfficerNRIX Nurix Therapeutics, Inc.$138Kdisclosed Sep 2 · filed the same day
  5. ▼ SELLChristine Ring Chief Legal OfficerNRIX Nurix Therapeutics, Inc.$10.7Kdisclosed Sep 2 · filed the same day
  6. ▼ SELLGwenn Hansen Chief Scientific OfficerNRIX Nurix Therapeutics, Inc.$37Kdisclosed Sep 1 · filed the same day
  7. ▼ SELLGwenn Hansen Chief Scientific OfficerNRIX Nurix Therapeutics, Inc.$64.3Kdisclosed Aug 5 · filed 1 day after the trade
  8. ▼ SELLGwenn Hansen Chief Scientific OfficerNRIX Nurix Therapeutics, Inc.$35.8Kdisclosed Aug 5 · filed 1 day after the trade
  9. ▼ SELLGwenn Hansen Chief Scientific OfficerNRIX Nurix Therapeutics, Inc.$109Kdisclosed Aug 5 · filed the same day
  10. ▼ SELLHoute Hans van Chief Financial OfficerNRIX Nurix Therapeutics, Inc.$73.1Kdisclosed Aug 4 · filed the same day
See every insider trade on NRIX →

Big holders (Schedule 13D / 13G): 4 filings in the last 90 days · newest: Perceptive Advisors LLC (13G), Sep 23, 2026 ↗

Filings & events

Company filings (8-K) 69

Events the company must report to the SEC within days — results, deals, departures, restatements.

What it files 8-Ks about

  • Other events · item 8.0113
  • Quarterly or yearly results · item 2.0211
  • Shared information with investors · item 7.0110
  • Signed a major agreement · item 1.013
  • Shareholder vote results · item 5.072
  • Directors or officers joined, left or got new pay · item 5.022

Filing red flags 24

Warning signs in the company's own SEC filings — going-concern doubts, control weaknesses, staff comment letters, late filings, restatements, Wells notices, clinical holds, dividend cuts.

FDA and clinical trials 1

Drug approvals, recalls, clinical-trial updates and FDA advisory meetings.

Planned insider sales (Form 144) 40

Notices insiders file before they sell certain shares, such as ones they got straight from the company.

7 in the last 90 days · 40 notices on file

The notices on file don't give the sale's size; each sale shows up under company insiders once it is reported.

5% owners (13D / 13G) 9

Investors who reported owning 5% or more — 13D for owners who may push for changes, 13G for owners who just hold.

Push for changes, or just hold?

  • 13D, may push for changes: 0 filings
  • 13G, just holds: 9 filings

Filed most: Fmr LLC (2) · Perceptive Advisors LLC (1) · Price T Rowe Associates Inc /Md/ (1) · Rubric Capital Management LP (1)

Biggest named funds (13F)

The largest NRIX holdings among the well-known funds whose quarterly 13F filings we read — opens here.

Every disclosed trade on NRIX

  1. ▼ SELLGwenn Hansen Chief Scientific OfficerNRIX Nurix Therapeutics, Inc.$36.3Kdisclosed Oct 15 · filed the same day
  2. ▼ SELLJulia P Gregory DirectorNRIX Nurix Therapeutics, Inc.$529Kdisclosed Oct 14 · filed the same day
  3. ▼ SELLChristine Ring Chief Legal OfficerNRIX Nurix Therapeutics, Inc.$134Kdisclosed Oct 2 · filed the same day
  4. ▼ SELLChristine Ring Chief Legal OfficerNRIX Nurix Therapeutics, Inc.$138Kdisclosed Sep 2 · filed the same day
  5. ▼ SELLChristine Ring Chief Legal OfficerNRIX Nurix Therapeutics, Inc.$10.7Kdisclosed Sep 2 · filed the same day
  6. ▼ SELLGwenn Hansen Chief Scientific OfficerNRIX Nurix Therapeutics, Inc.$37Kdisclosed Sep 1 · filed the same day
  7. ▼ SELLGwenn Hansen Chief Scientific OfficerNRIX Nurix Therapeutics, Inc.$64.3Kdisclosed Aug 5 · filed 1 day after the trade
  8. ▼ SELLGwenn Hansen Chief Scientific OfficerNRIX Nurix Therapeutics, Inc.$35.8Kdisclosed Aug 5 · filed 1 day after the trade
  9. ▼ SELLGwenn Hansen Chief Scientific OfficerNRIX Nurix Therapeutics, Inc.$109Kdisclosed Aug 5 · filed the same day
  10. ▼ SELLHoute Hans van Chief Financial OfficerNRIX Nurix Therapeutics, Inc.$73.1Kdisclosed Aug 4 · filed the same day
  11. ▼ SELLHoute Hans van Chief Financial OfficerNRIX Nurix Therapeutics, Inc.$42.9Kdisclosed Aug 4 · filed the same day
  12. ▼ SELLChristine Ring Chief Legal OfficerNRIX Nurix Therapeutics, Inc.$382Kdisclosed Aug 3 · filed the same day
  13. ▼ SELLChristine Ring Chief Legal OfficerNRIX Nurix Therapeutics, Inc.$90Kdisclosed Jul 30 · filed the same day
  14. ▼ SELLHoute Hans van Chief Financial OfficerNRIX Nurix Therapeutics, Inc.$66.5Kdisclosed Jul 30 · filed the same day
  15. ▼ SELLGwenn Hansen Chief Scientific OfficerNRIX Nurix Therapeutics, Inc.$90Kdisclosed Jul 30 · filed the same day
  16. ▼ SELLChristine Ring Chief Legal OfficerNRIX Nurix Therapeutics, Inc.$259Kdisclosed Jul 2 · filed the same day
  17. ▼ SELLChristine Ring Chief Legal OfficerNRIX Nurix Therapeutics, Inc.$581Kdisclosed Jun 25 · filed the same day
  18. ▼ SELLGwenn Hansen Chief Scientific OfficerNRIX Nurix Therapeutics, Inc.$108Kdisclosed Jun 25 · filed the same day
See the trades on NRIX in the feed →
People & votes

Which members of Congress traded NRIX, sponsored bills that touch it and voted on them — opens here.